Search details
1.
Identification of a Notch transcriptomic signature for breast cancer.
Breast Cancer Res
; 26(1): 4, 2024 01 03.
Article
in English
| MEDLINE | ID: mdl-38172915
2.
Predicting the clinical outcomes and benefit from letrozole after 5 years of treatment with aromatase inhibitors for early breast cancer: analysis from CCTG MA.17R.
Breast Cancer Res Treat
; 191(3): 523-533, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34825307
3.
ZNF423 modulates the AMP-activated protein kinase pathway and metformin response in a single nucleotide polymorphisms, estrogen and selective estrogen receptor modulator dependent fashion.
Pharmacogenet Genomics
; 31(7): 155-164, 2021 09 01.
Article
in English
| MEDLINE | ID: mdl-34001842
4.
Single-nucleotide polymorphism biomarkers of adjuvant anastrozole-induced estrogen suppression in early breast cancer.
Pharmacogenet Genomics
; 31(1): 1-9, 2021 01.
Article
in English
| MEDLINE | ID: mdl-32649577
5.
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.
N Engl J Med
; 379(2): 122-137, 2018 Jul 12.
Article
in English
| MEDLINE | ID: mdl-29863451
6.
A clinical calculator to predict disease outcomes in women with triple-negative breast cancer.
Breast Cancer Res Treat
; 185(3): 557-566, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-33389409
7.
Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307).
Support Care Cancer
; 29(5): 2509-2517, 2021 May.
Article
in English
| MEDLINE | ID: mdl-32929540
8.
ERß-mediated induction of cystatins results in suppression of TGFß signaling and inhibition of triple-negative breast cancer metastasis.
Proc Natl Acad Sci U S A
; 115(41): E9580-E9589, 2018 10 09.
Article
in English
| MEDLINE | ID: mdl-30257941
9.
Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer.
Breast Cancer Res
; 22(1): 51, 2020 05 19.
Article
in English
| MEDLINE | ID: mdl-32430040
10.
Optimized immunohistochemical detection of estrogen receptor beta using two validated monoclonal antibodies confirms its expression in normal and malignant breast tissues.
Breast Cancer Res Treat
; 179(1): 241-249, 2020 Jan.
Article
in English
| MEDLINE | ID: mdl-31571071
11.
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015.
Breast Cancer Res Treat
; 181(3): 623-633, 2020 Jun.
Article
in English
| MEDLINE | ID: mdl-32378051
12.
SNPs near the cysteine proteinase cathepsin O gene (CTSO) determine tamoxifen sensitivity in ERα-positive breast cancer through regulation of BRCA1.
PLoS Genet
; 13(10): e1007031, 2017 Oct.
Article
in English
| MEDLINE | ID: mdl-28968398
13.
The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1.
Breast Cancer Res
; 21(1): 47, 2019 04 03.
Article
in English
| MEDLINE | ID: mdl-30944027
14.
Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancer.
Pharmacogenet Genomics
; 29(8): 183-191, 2019 10.
Article
in English
| MEDLINE | ID: mdl-31211741
15.
Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.
N Engl J Med
; 375(3): 209-19, 2016 Jul 21.
Article
in English
| MEDLINE | ID: mdl-27264120
16.
4-Hydroxytamoxifen enhances sensitivity of estrogen receptor α-positive breast cancer to docetaxel in an estrogen and ZNF423 SNP-dependent fashion.
Breast Cancer Res Treat
; 175(3): 567-578, 2019 Jun.
Article
in English
| MEDLINE | ID: mdl-30937657
17.
Metaplastic breast cancer has a poor response to neoadjuvant systemic therapy.
Breast Cancer Res Treat
; 176(3): 709-716, 2019 Aug.
Article
in English
| MEDLINE | ID: mdl-31119569
18.
NOTCH3 expression is linked to breast cancer seeding and distant metastasis.
Breast Cancer Res
; 20(1): 105, 2018 09 04.
Article
in English
| MEDLINE | ID: mdl-30180881
19.
Germline genome-wide association studies in women receiving neoadjuvant chemotherapy with or without bevacizumab.
Pharmacogenet Genomics
; 28(6): 147-152, 2018 06.
Article
in English
| MEDLINE | ID: mdl-29768301
20.
Adjuvant ovarian suppression in premenopausal breast cancer.
N Engl J Med
; 372(5): 436-46, 2015 Jan 29.
Article
in English
| MEDLINE | ID: mdl-25495490